Article Information
Volume 23, Issue 19, pp. 5729-5736
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 18, 2017
- Revision received June 28, 2017
- Accepted July 14, 2017
- Published first October 1, 2017.
Copyright & Usage
©2017 American Association for Cancer Research.
Author Information
- Yulian Khagi1,*,
- Aaron M. Goodman1,2,
- Gregory A. Daniels3,
- Sandip P. Patel1,
- Assuntina G. Sacco3,
- James M. Randall3,
- Lyudmila A. Bazhenova3, and
- Razelle Kurzrock1
- 1Department of Medicine, Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, California.
- 2Department of Medicine, Blood and Bone Marrow Transplant Program, Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, California.
- 3Department of Medicine, Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, California.
- ↵*Corresponding Author:
Yulian Khagi, University of California San Diego Moores Cancer Center, 3855 Health Sciences Drive, 0987, La Jolla, CA 92093. Phone: 858-822-6100; Fax: 858-822-6186; E-mail: ykhagi{at}ucsd.edu
October 2017
Volume 23, Issue 19
Volume 23, Issue 19
Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor–Based Immunotherapy
Jump to section
Advertisement